RTA-3
GIP / GLP-1 / Glucagon Triple Agonist
Add $70.05 to unlock 7.5% off.
Free shipping over $225
About RTA-3.
Retatrutide is a 39-amino-acid peptide classified as a triple agonist, meaning it targets the GIP, GLP-1, and glucagon receptors simultaneously. This combined receptor activity makes it a distinctive subject in metabolic research. In research models it is studied for its effects on metabolic regulation, appetite, and body-composition outcomes. It is supplied as a lyophilized powder requiring frozen storage for stability, in 10mg, 15mg, and 30mg sizes. This product is intended for research and laboratory use only. It is not for human consumption.
All material supplied for research use only. Not for human consumption. Not intended to diagnose, treat, cure, or prevent any disease.
- ◆1 × sealed vial — 30mg / 15mg / 10mg lyophilized RTA-3
- ◆Tamper-evident pharma-grade packaging
- ◆Batch-specific COA (also available online)
The full sheet.
- Molecular formula
- C₂₂₁H₃₄₂N₄₆O₆₈
- Form
- Lyophilized powder
- Category
- Metabolic
- Net weight
- 30mg / 15mg / 10mg
- Reconstitution
- Bacteriostatic water (0.9% benzyl alcohol)
- Storage
- Lyophilized: −20°C, sealed & protected from light. Reconstituted: 2–8°C, use within 30 days.
Every batch verified.
Third-party HPLC and mass spectrometry on every lot. The full COA for this batch is below, with peak chromatogram and signed lab report.
